Guest Editors
KANDASAMY SARAVANAKUMAR
Kangwon National University, Chunchoen, Gangwon do, Korea
saravana732@gmail.com
GOPINATH VENKATRAMAN
University of Malaya, Kuala Lumpur, Malaysia
Yele.gopi@gmail.com
SUBASH C B GOPINATH
Universiti Malaysia Perlis, Perlis, Malaysia
subash@unimap.edu.my
MYEONG-HYEON WANG
Kangwon National University, Chunchoen, Gangwon do, Korea
mhwang@kangwon.ac.kr
Summary
Cancer is a multifactorial disease that remains a major threat to public health worldwide. Thus, identifying potential anticancer products such as novel biological compounds from various phytochemical constituents, natural and synthetic compounds, and nanoparticles-drug conjugates. Most medicinally plant-derived compounds and metabolites are widely used for anticancer therapeutics, which may demonstrate less toxicity to normal cells over anticancer drugs. This special issue focuses on the current and future applications of natural and synthetic products and their potential application in cancer therapeutics. Small molecules, Natural compounds, Metal, metal oxide and polymeric nanocomposites in-vitro and in vivo anti-cancer activity, apoptosis and identifying their mechanism of action. The authors are encouraged to submit original research novel secondary metabolites, drug targets, and cancer therapy advancement. It is projected that this Special Issue will value researchers in cancer biomedicine and enlighten the ongoing and future advancement associated with cancer drug discovery and development.
Keywords
immune nanomedicine, Organic and inorganic nanoparticles, Metabolites, nanoparticles drug conjugates, cancer, therapy
Published Papers
Login
Register
Submit a Paper
Propose a Special lssue